Try our beta test site
8 studies found for:    "membranoproliferative glomerulonephritis type II" OR "Glomerulonephritis, Membranoproliferative"
Show Display Options
Download search resultsDownload the search results for:
"membranoproliferative glomerulonephritis type II" OR "Glomerulonephritis, Membranoproliferative" (8 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Conditions: Dense Deposit Disease;   Membranoproliferative Glomerulonephritis Type II;   C3 Glomerulonephritis
Intervention: Drug: CDX-1135
2 Unknown  Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Conditions: Dense Deposit Disease;   Membranoproliferative Glomerulonephritis
Intervention: Drug: Eculizumab
3 Completed Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
Condition: Glomerulonephritis, Membranoproliferative
Intervention: Drug: Rituximab
4 Withdrawn Sulodexide Treatment in Patients With Dense Deposit Disease
Condition: Dense Deposit Disease
Intervention: Drug: Sulodexide
5 Active, not recruiting Eculizumab in Primary MPGN
Condition: Membranoproliferative Glomerulonephritis
Intervention: Drug: Eculizumab
6 Withdrawn TP10 Use in Patients With C3 Glomerulopathy (C3G)
Condition: Dense Deposit Disease
Intervention: Drug: TP10
7 Completed BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
Conditions: Glomerulonephritis, Membranoproliferative;   Lupus Nephritis
Intervention: Drug: BG9588
8 Recruiting Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Conditions: IgAN;   Lupus Nephritis;   MN;   C3G
Interventions: Biological: OMS721;   Other: Vehicle (D5W)

Study has passed its completion date and status has not been verified in more than two years.